Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa
    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa
    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa
    Ebook389 pages4 hours

    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa

    By Ulla Hedner

    ()

    Read preview

    About this ebook

    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa provides a comprehensive understanding of the first new drug within the area of hemostasis, describing a new mechanism of action that has resulted in a modified concept of the whole hemostasis mechanism. As the treatment of life-threatening bleedings is a serious challenge for clinicians, this powerful and historic case study presents a detailed roadmap on how a new medicine can be developed, stressing the interaction between science and clinical work.

    The book stresses the importance of patient care in the learning process and provides new ideas on how to approach diseases and their treatment. Users will find a real world example that will act as a timely resource for those learning about, or engaged in, performing and supervising research across the biomedical sciences.

    • Documents the successful roadmap of the development of a new concept of treating major bleedings in the most life-threatening situations
    • Stresses the importance of the close connection between the clinic and research, describing how a new concept of hemostasis was revealed by careful clinical observation
    • Offers real-world research and development context for drug discovery, and for the treatment of hemophilia and other bleeding disorders
    LanguageEnglish
    PublisherAcademic Press
    Release dateJul 4, 2017
    ISBN9780128124406
    Treating Life-Threatening Bleedings: Development of Recombinant Coagulation Factor VIIa
    Author

    Ulla Hedner

    Dr. Hedner has been active in the field of Thrombosis and Haemostasis for more than 40 years and initiated the idea to use FVIIa as a hemostatic drug when working as a clinician at the University Hospital of Malmö, Lund University, Sweden, in the 1970s. Later, she led the development of recombinant FVIIa when being part of the Department of Research & Development at the Danish pharmaceutical company Novo Nordisk A/S, Bagsværd, Denmark. Dr. Hedner was a physician at the Department of Bleeding Disorders including a Haemophilia Comprehensive Clinic, Malmö University Hospital, University of Lund, Sweden from 1972-1983 . Her research and teaching experience was at the Medical Faculty of Lund University, Sweden and Professor in Clinical Coagulation Research at the University of Gothenburg and at the University of Lund.

    Related to Treating Life-Threatening Bleedings

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: Drug Sensitivity And Resistance Testing Could Make ‘Right To Try’ A Real Thing

      Oct 9, 2018

      There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.

      3 min read

    • Article

      Hispanic Patients On Ventilators Are More Likely To Be Heavily Sedated

      Feb 15, 2024

      Hispanic patients who are hospitalized with respiratory failure are five times more likely than non-Hispanic patients to receive deep sedation while on a ventilator, according to a new study. The study is the first to identify what may be driving wor

      2 min read

    • Article

      Chasing The Cure

      Oct 10, 2020

      Chasing The Cure
      6 min read

    • Article

      Opinion: Preprints Can Fill A Void In Times Of Rapidly Changing Science

      Jan 31, 2020

      During public health crises, researchers, public health experts, clinicians, and others must rapidly exchange information, provide constructive critiques, share data, and seek — above all — to put the public's…

      4 min read

    • Article

      Watchdog Group Calls For NIH To Halt ‘Dangerous’ Study Of Sepsis Treatment

      Aug 28, 2018

      A medical watchdog group contends patients in an NIH-funded trial are “unwitting guinea pigs in a physiology experiment that will not advance medical care for sepsis.”

      4 min read

    • Article

      Chest Pain Drug Doesn’t Cut Risk Of First Irregular Heart Beat

      Sep 6, 2018

      While a drug commonly used to treat chest pain is safe for people with certain implantable defibrillators, it doesn’t significantly decrease the likelihood of the first occurrence of an irregular heart beat or death, according to a new clinical trial

      2 min read

    • Article

      The Integrating Fields Of Medicine + Oncology

      Aug 31, 2018

      People diagnosed with cancer and their families often use therapies such as acupuncture, exercise, diet and meditation to cope with the physical, emotional, and spiritual effects of the cancer, and in search of relief from symptoms that their convent

      5 min read

    • Article

      New Guidelines Aim To Enlist Primary Care Physicians In Transgender Care

      Jul 1, 2019

      In a move that reflects a growing acceptance of transgender individuals in the U.S., the American College of Physicians just issued its first guidelines on caring for transgender patients.

      3 min read

    • Article

      Discussing Death Doesn’t Harm Doctor-patient Bond

      Dec 4, 2017

      Talking through bad news can be good for the doctor-patient relationship, research shows. The researchers cite an example of a difficult question from an actual conversation in an oncologist’s office: “Have you had thoughts about stopping the chemoth

      1 min read

    • Article

      Safer Blood Products: One Researcher’s Story on Why Federal Support Matters

      Apr 12, 2017

      In 1982, a crisis was beginning to unfold. Gay men were dying of an unknown cause, which years later was shown to be the Human Immunodeficiency Virus (HIV).  At that time, I was not involved with the gay community, with acquired immunodeficiency synd

      3 min read

    • Article

      On The Front Lines

      Jul 27, 2021

      On The Front Lines
      3 min read

    • Article

      Open Source Drug Discovery: Global Solutions to Global Problems

      Mar 31, 2017

      ARTICLE BY: DR ALICE E WILLIAMSON People who live without adequate sanitation are exposed to more diseases; people who live outside of adequate healthcare infrastructure may not receive diagnosis or prescription medicines; and people living with, or

      9 min read

    • Article

      After Big Gains, Cystic Fibrosis Foundation Bankrolls Research Toward Cures — And Drugs For Those Left Out

      Oct 30, 2019

      Last week, the cystic fibrosis community celebrated the approval of another new drug for patients. But, advocates say, much work remains to be done.

      3 min read

    • Article

      Canada Case Highlights Possible Long-term Risks Of Experimental Stem Cell Therapy

      Jul 11, 2019

      The worst-case scenario for stem cell therapy isn't that it doesn't work, but that it causes problems like the growth of a tumor down the road.

      5 min read

    Related categories

    Reviews for Treating Life-Threatening Bleedings

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Treating Life-Threatening Bleedings - Ulla Hedner

      K_book_preview_excerpt.html\ےG] HY $;03#CTfTeF^(=fv~`?a~`D_{䥺Y32##z'OgUY"k}N~<{ۺ={gZuOpar^UٮUz\xyU$w{l'1BlhCK'J)tɦ1idK۰\/Kmܗu׻>Id:%5TuF+ЭW}twCakEyRnSXl|ymZ ч*}ۅ( 6qEW'J!㹚ܵ%d5`seQ`\ս,_xnnNqI[[haӦ\{L5tC/Cq]hL鳐ʛg/\eL'Pѻî7xu]WQJn㸐76;Cmm|ky!8 QviY$uSL:xȭk-Άs*\[aoD41.IGV|J^*+w_,KXg7$!J]+k#ʕBO1,]UZ@Ԋ spGMz'nzSPqa4wE᫝`I\ȥWƩeZ}N̠W<-%* :-0 IC=tP&#UQ>m"]A\:uPav.TP#I8UzE9.6WY>g_o|[>8h֢6d;?~D؀o#ȉGkc_7Mff/ =wM޸?Wbk&9N9 |U6C^T%?'MM:F{yIAUz B=O?>"LO X7w8:lA|?zLbsfRCaTk^}b.+H>k'C('Kf2u=Q^ 1>񀲹e^7[M;ʣza%{Va989dm,ןTzþţ3l%2tm]do"jNH ?y k| ELVW'3q_m)r`@@";'H]&#ºG250t}"&ūFm~Ӯxf"W63>LL53Z9/b*D.)j"]к+RsIH6ԙ80RB+7gg *n';Z &1=mN%!{*(Y:l=13v;ɮ3n"^Uس&5ĝRTW*PvԖfAV9IhX%/7n=Ks7C.@zZ{k-=ΛKfgdwZ#'7L 1#7M EHrTM-(q9øA*l_{#aokӚ4l=s+`"$Qҏ`ʡ4)[\]x$ۯl5O%Wq߅. Pk ƥ(<kt ~m+9 ,.9GYeƂ@Ε+O ?k8VLT+?(f`amC . >$eA[%Uj\[gt"h*oQ~G F1X'~ |M+[=h͔ʰ!ntX~ KC {P!}Ц'6C lB^V~ܠ/VVثǒ x cy _e4m.计$Ж9A /j+c;>Wʷ; L`{LC}NcJ NRcb TЊĽnJ[#q}@r9X•eg|+Wy<ɟLՋry6MUS?ϠoL 5SR7T%?*V,ت1^/ϋn)/J^iM[x˓d]1RS[T Z ̋>8uy2 ci_3W5<% bS;-MW,p1BrV>i" - J (=:0N[%ZZ2 v(n'VR'r-r#qi1izer8@8bnԑ2㶍f6}].c5roa#Z|4mOr Zć PuQi>VxvP݈pXϙׂڬl7N8u؃䍨3(~&2ݪ1) oD=Iiu%+_!&MHAROQ݋[q@H*{_uIi^IU/ڤ` q v -b*Kk6Hɐqk!$#)S+\1i:lҟ lN LAN^9Lm,H8?LY2Uovo)ґjMT'9 9*y~zZRַip&f^HȆa%ts_'5bua1VK >ACFlRD*aKAַ87JLlp:Sԙce%ӢnA2 IsѸT^Wc(lpr.KZ%7 P[N5q1`t;E"< t.{3PÐPrA>h;;P7`"<ZgDGt4ھV'CX]ձPPA`T 8h>tWM 蘾/KX* Q6j.xoiHFD2VIN4[Bq)$""‹$,HګfؙѴEyV# -`$/| U7]ti'NH>k/;ĘܙX'/7-ie2}JGزtx! ^KM^(b &$"yrq Pl 7RQSAC6dmŚB\~,Q}=ݘ82g:88`Z:rρ58}fLmH", rpX}rq}E#Gr6jh"/Z<DO_c֟.™n 6UiZU&'T^z¤NhYTG4Ο/_:e\ӶlLGH8 ~s[a='ZP%x7HGv)mrW)z_17`fJg³Q[[nB bryĻ[ @2DO)W"nJ˃g#yq |Z' ON YL'('$İ넝Apԓ{OMFd. ˋ')NQy^؈/%~><;_g'?c3}isM.賋ĝ|+pvۯ;.>l {iϟf@/{g&I[fd>onvk.3ԑܪ[[sY-#%l*Éb*o{GB|>kLvB. Тmsq8&n)ǰԷ4uiy@h?Nf2cyq()}TʬEQxiZ"@ DZ5ђ FTv}mVrjG)NМYBMjXw,.h1NR5{GNKlҠ yh˼¥$ˆïעr_j3.QtGu&$d8EH&`, ,R v(?:;P$L\ZjRb;qV`I/!QO빉d1(CsIgD-å%B+2jEqj3ZuM53T]l,˳%H>̺r}~2SX1U8?:y=dRo\H:$eAtX9]43&$)ȲmpL;f8+in2ɧPTk -a-f( Gw4X&wS˔x*[ @rf/dGlNf(XW?U:*G߃;߆:ArĘ9+*&1;\j-E-& [>Oesw|X{$WSնVf4ɒ4Dڀ,C!cE! `gmqi|XxzIt}b qpDWa|BƝqSTGN9Q^)WFܝסco;4mQ}D?~,fHgÍji1z5A#rA (Gb|q Ȯ[Ee! {Xbsa}d[o5Mkn3J[-j\#y{! mbe@Ύ*Tfc V7IzŌe0j2tJț`UZx6N*3adzYy01ⓠKRԶ*(-ԖcW“ptsh5PR10Y8_֕ ιf-#6O,gަM9x8;LK%OjOxN&"Or2=ij\yc+|N] \ֺmYMx܏l>!SQ8,"9][&s꒳6CJ3ʠj,`s ȿ;㍕$MzB1TB>Y33Ae%B*k o%Q[ #N!u,~5m{j.G'c8Ic-jmsFAշ좎+&oȌZ {rAGdfVdO*ښY .6%^+ G q~J[' vRթ(8QSˋ'SD֒b:]Ƶ(<7x~Ӭ "7'X~~&-S]tϗq&Hr lD ŹjsCz2Ո|JGNSƵ]Ҫ+DaløESb9β&Ȑ&pR^("K!2_xGxJ +҆s!\ހ[H$4R@}##(7q/K,ebUrgv|V y@9(ӷ&G%.ByH#>[&.Och^1oWR$T>iq +CO 4EIZ]Y$W~efwv'6_eWiN߮0,l28/A W- ٛSZ9u*>LEn|.O*^ vrُx[ڠ-S:eYWI4bsp)t2(?4_ExmIev; {2OgOC܎FE(F̖s/% F)1 NrV}p 8f~ Sm5 4`N6wOZ E!0[6lʩY3W a4+cVb(I{.iyw}$ެ; cQrF&{Mэ[w='{g˔"~hXlMjȭ){YkY_|1y!չ^l["cT< Z[J&JX0O 2H oeZN&cҼ N]w.t. ؾ7kFl+; *@SĕAxN[m~;d{+\nfح]*vN LTtܓhv_ :%eN@ޠ7N$m]e|N2.WuchicޑMJT5S%HEt|w"$16V5m56mXUO-,}`r~"z^O;rLh̳JhKęD{l6lim8_G{x
      Enjoying the preview?
      Page 1 of 1